Dr. David Jay Parks, MD

Dr. Parks practices at Beverly Hills Endoscopy LLC in Beverly Hills, California.

Dr. Parks' NPI, 1841381688, was assigned on September 27, 2006. Dr. Parks graduated from WashU Medicine in 1988. Dr. Parks holds California license G78517.

Dr. Parks' primary practice is Beverly Hills Endoscopy LLC, at 8920 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 888-8898.

Dr. Parks' primary practice is Beverly Hills Endoscopy LLC in Beverly Hills, California. Dmand AI also links Dr. Parks to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parks practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Parks' primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Parks is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Parks' licenses on file in 4 states: California, Guam, Pennsylvania and Maryland.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Parks treats.

CMS data shows 40,941 Medicare services from Dr. Parks across 23 procedure codes in 2024, for 984 Medicare patients. Medicare paid $3,440,604 for them.

CMS counts 984 Medicare patients who saw Dr. Parks in 2024. The largest group is 65 to 74, with 367 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parks' median patient age at 66, with 44% women.

In 2024, Dr. Parks wrote 517 Medicare Part D claims for 131 patients. 57% of them were for generic drugs. CMS names the drug for 437 of them, across 8 drugs with 11 or more claims each, at $8,060 in total drug cost. In 2023, CMS named 408 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Parks for performance year 2024, reported individually. Dr. Parks accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Parks. The most frequent topics are Antiviral Agents, Cytomegalovirus Retinitis and Drug Implants. Dr. Parks has published most often in Arch Ophthalmol. Dr. Parks' most frequent co-authors are David G. Callanan, MD, Kourosh Dastgheib, MD and Wayne A. Solley, MD.

CMS Open Payments shows 36 general payments to Dr. Parks from 10 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 96% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $478.

Dmand AI lists 1 award for Dr. Parks.

Dr. Parks graduated from WashU Medicine in 1988. Dr. Parks is a member of AAO.

Dr. Parks is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.